JAMA Network
About The Study: In this study of 103,000 individuals with early-stage breast cancer, Black patients had a higher mortality risk compared with white patients among those with residual disease after neoadjuvant chemotherapy. This highlights the need for personalized treatment strategies for Black patients to help them attain pathologic complete response.
Authors: Shipra Gandhi, M.D., of Roswell Park Comprehensive Cancer Center in Buffalo, New York, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.44517)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
